Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Enbrel® (etanercept) – New indication
October 18, 2023 - The FDA approved Amgen’s Enbrel (etanercept), for the treatment of active juvenile psoriatic arthritis (JPsA) in pediatric patients 2 years of age and older.
